Skip to main content
Livermore
Livermore
ZHEN

Jasper Therapeutics, Inc.

JSPR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001788028

No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.

Other share classesJSPRW

13F holders, Q2 2023

Institutional positions in Jasper Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
+1 vs. Q1 2023
Shares held
88.1M
−5.53M (−5.9%) vs. Q1 2023
Total value
$120.0M
−$48.8M (−28.9%) vs. Q1 2023
New holders
13
7 more added
Sold out
12
10 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 46 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 9 institutionsQ4 2021: 25 institutionsQ1 2022: 24 institutionsQ2 2022: 23 institutionsQ3 2022: 23 institutionsQ4 2022: 23 institutionsQ1 2023: 45 institutionsQ2 2023: 46 institutionsQ3 2023: 41 institutionsQ4 2023: 42 institutionsQ1 2024: 61 institutionsQ2 2024: 69 institutionsQ3 2024: 81 institutionsQ4 2024: 88 institutionsQ1 2025: 69 institutionsQ2 2025: 65 institutionsQ3 2025: 60 institutionsQ4 2025: 55 institutionsQ1 2026: 58 institutionsQ2 2026: 45 institutions
Value heldQ2 2023: $120.0M
Q1 2021: $0Q2 2021: $0Q3 2021: $101.4MQ4 2021: $160.7MQ1 2022: $69.6MQ2 2022: $37.5MQ3 2022: $15.7MQ4 2022: $9.57MQ1 2023: $168.8MQ2 2023: $120.0MQ3 2023: $63.7MQ4 2023: $61.2MQ1 2024: $380.2MQ2 2024: $329.8MQ3 2024: $274.8MQ4 2024: $334.5MQ1 2025: $56.1MQ2 2025: $69.5MQ3 2025: $47.8MQ4 2025: $35.2MQ1 2026: $13.9MQ2 2026: $5.05M
Institutions holding JSPR and their total value by quarter
QuarterHoldersValue
Q2 202645$5.05M
Q1 202658$13.9M
Q4 202555$35.2M
Q3 202560$47.8M
Q2 202565$69.5M
Q1 202569$56.1M
Q4 202488$334.5M
Q3 202481$274.8M
Q2 202469$329.8M
Q1 202461$380.2M
Q4 202342$61.2M
Q3 202341$63.7M
Q2 202346$120.0M
Q1 202345$168.8M
Q4 202223$9.57M
Q3 202223$15.7M
Q2 202223$37.5M
Q1 202224$69.6M
Q4 202125$160.7M
Q3 20219$101.4M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding JSPR in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada260$00.00%+260New
Barclays PLC249$3410.00%+249New
Cutler Group LP900$1.00K0.00%00.0%Unchanged
Simplex Trading, LLC924$1.00K0.00%+924New
Wells Fargo & Company797$1.09K0.00%+35+4.6%Added
Group One Trading, L.P.8,292$11.4K0.00%+8,292New
Tower Research Capital LLC (TRC)9,397$12.9K0.00%+9,397New
Virtu Financial LLC10,940$15.0K0.00%+10,940New
XTX Topco Ltd11,286$15.5K0.00%+11,286New
Millennium Management LLC18,428$25.2K0.00%−36,290−66.3%Reduced
One68 Global Capital, LLC20,000$27.4K0.17%00.0%Unchanged
Gries Financial LLC23,845$32.7K0.01%+23,845New
Charles Schwab Investment Management Inc36,899$50.6K0.00%00.0%Unchanged
HRT Financial LP41,263$56.0K0.00%+41,263New
Bank of New York Mellon Corp43,593$59.7K0.00%00.0%Unchanged
Renaissance Technologies LLC58,100$80.0K0.00%−52,100−47.3%Reduced
Forefront Analytics, LLC69,367$95.0K0.05%+39,077+129.0%Added
Legal & General Group Plc80,000$109.6K0.00%+80,000New
Northern Trust Corp154,909$212.2K0.00%−377−0.2%Reduced
State Street Corp199,094$272.8K0.00%00.0%Unchanged
Boothbay Fund Management, LLC233,159$319.4K0.01%−248−0.1%Reduced
Morgan Stanley321,550$440.5K0.00%−56,522−15.0%Reduced
Fernwood Investment Management, LLC454,706$622.9K0.22%00.0%Unchanged
Affinity Asset Advisors, LLC476,948$653.4K0.26%00.0%Unchanged
Jefferies Financial Group Inc.489,884$671.1K0.01%+489,884New
Silverarc Capital Management, LLC500,000$685.0K0.23%00.0%Unchanged
Mariner, LLC714,996$979.5K0.00%+714,996New
Geode Capital Management, LLC965,504$1.32M0.00%−104,810−9.8%Reduced
Ikarian Capital, LLC1,125,087$1.54M0.54%−1,200−0.1%Reduced
BlackRock Inc.1,332,347$1.83M0.00%+75,830+6.0%Added
Citadel Advisors LLC1,426,022$1.95M0.00%−2,587,016−64.5%Reduced
Bank of America Corp2,252,096$3.09M0.00%+470,513+26.4%Added
Nantahala Capital Management, LLC2,477,880$3.39M0.41%+789,426+46.8%Added
Ally Bridge Group (NY) LLC2,517,232$3.45M4.18%00.0%Unchanged
Altium Capital Management LP2,868,000$3.93M3.07%+2,868,000New
Woodline Partners LP3,000,000$4.11M0.05%00.0%Unchanged
Kingdon Capital Management, L.L.C.3,040,000$4.16M0.73%00.0%Unchanged
Vanguard Group Inc3,688,358$5.05M0.00%−37,789−1.0%Reduced
Sphera Funds Management Ltd.4,274,008$5.86M1.25%+230,000+5.7%Added
Octagon Capital Advisors LP4,468,114$6.12M0.85%−1,914,386−30.0%Reduced
Franklin Resources Inc4,500,217$6.17M0.00%00.0%Unchanged
Soleus Capital Management, L.P.7,775,980$10.7M1.18%+321,000+4.3%Added
Qiming U.S. Ventures Management, LLC8,519,648$11.7M12.26%00.0%Unchanged
Carlyle Group Inc.8,761,891$11.8M0.42%00.0%Unchanged
BVF Inc9,900,000$13.6M0.38%00.0%Unchanged
Velan Capital Investment Management LP11,219,036$14.8M13.94%00.0%Unchanged
Driehaus Capital Management LLC0$00.00%−4,000,000−100.0%Sold out
RTW Investments, LP0$00.00%−2,329,809−100.0%Sold out
Jane Street Group, LLC0$00.00%−211,010−100.0%Sold out
Squarepoint Ops LLC0$00.00%−139,887−100.0%Sold out
Man Group plc0$00.00%–Sold out
Citigroup Inc0$00.00%−64,810−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−54,500−100.0%Sold out
Two Sigma Investments, LP0$00.00%−42,253−100.0%Sold out
Jump Financial, LLC0$00.00%−33,074−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−31,041−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−13,822−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−350−100.0%Sold out